This inventor holds 36 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Schering Aktiengesellschaft, Bayer Schering Pharma Ag, Scnering Aktiengesellschaft. Active years: 1980-2010.
Company Filing History:
33 out of 1,409 
1 out of 192 
1 out of 1 Years Active: 1980-2010
Areas of Expertise:
Title: Herbert H. Schneider - Innovator in Pharmaceutical Chemistry
Introduction
Herbert H. Schneider, based in Berlin, Germany, is an accomplished inventor known for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 36 patents, Schneider has dedicated his career to the development of innovative pharmaceutical agents targeting various health conditions.
Latest Patents
Schneider's latest patents include novel 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, which have potential uses in treating and preventing diseases associated with microglia activation and T-cell-mediated immunological disorders. His work describes the production and application of these new benzimidazole derivatives in pharmaceutical preparations, emphasizing their therapeutic potential. Additionally, he has developed 1-aryl-2-N-, S-, or O-substituted benzimidazole derivatives, which also target similar health issues. The inventions revolve around the general formula of these compounds and their application in creating effective pharmaceutical agents.
Career Highlights
Throughout his career, Herbert H. Schneider has made significant strides in the pharmaceutical industry. He has notably worked at Schering Aktiengesellschaft, a global leader in pharmaceuticals, where he honed his expertise and contributed to various research initiatives aimed at drug development.
Collaborations
Schneider has collaborated with esteemed professionals in the field, including colleagues Andreas Huth and Dieter Seidelmann. These partnerships have bolstered his innovative efforts and have facilitated advancements in the pharmaceutical domain.
Conclusion
Herbert H. Schneider stands out as a prominent figure in pharmaceutical innovation. His extensive experience and portfolio of patents underscore his commitment to enhancing healthcare through the development of novel therapeutic agents. As the pharmaceutical landscape continues to evolve, Schneider's contributions will undoubtedly leave a lasting impact.